RetiVue DR, a point and shoot, non-mydriatic, widefield retinal camera for diabetic eye screening
Award amount
$1,774,390Program and phase
SBIR · Phase II – Direct to Phase IIAward year
2017Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- RETIVUE LLC
- Proposal award date
- 2017-09-30
- Contract end date
- 2019-08-31
- UEI
- HKJ8UAHR73M3
- Solicitation number
- PAR14-088
- Topic code
- N
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- RetiVue EntireEye - A Handheld, High-Resolution, Non-Contact, One Image, Widefield Retinal Screening Camera for Premature and Healthy Newborn Babies
- RetiVue EntireEyeScope: A high resolution, top-down view, stereo, endoscopic viewing system for vitreoretinal surgery
- RetiVue WF - A Handheld, High-Resolution, Widefield Retinal Imager
- RetiVue WF - A Handheld, High-Resolution, Wide-field Retinal Imager
- Identifying Novel Targets for Recruitment of Brown Adipocytes
Research funding history
6 SBIR/STTR records share this UEI (2013–2025). Reported award amounts total $5,870,727. Reported amounts are not federal obligations.
Phases: Phase II, Phase I, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services